Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision
|
|
- Clarence Carter
- 5 years ago
- Views:
Transcription
1 Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
2 Nigeria: WHO and UNICEF estimates of immunization coverage: 2017 revision BACKGROUND NOTE: Each year WHO and UNICEF jointly review reports submitted by Member States regarding national immunization coverage, finalized survey reports as well as data from the published and grey literature. Based on these data, with due consideration to potential biases and the views of local experts, WHO and UNICEF attempt to distinguish between situations where the available empirical data accurately reflect immunization system performance and those where the data are likely to be compromised and present a misleading view of immunization coverage while jointly estimating the most likely coverage levels for each country. WHO and UNICEF estimates are country-specific; that is to say, each country s data are reviewed individually, and data are not borrowed from other countries in the absence of data. Estimates are not based on ad hoc adjustments to reported data; in some instances empirical data are available from a single source, usually the nationally reported coverage data. In cases where no data are available for a given country/vaccine/year combination, data are considered from earlier and later years and interpolated to estimate coverage for the missing year(s). In cases where data sources are mixed and show large variation, an attempt is made to identify the most likely estimate with consideration of the possible biases in available data. For methods see: *Burton et al WHO and UNICEF estimates of national infant immunization coverage: methods and processes. *Burton et al A formal representation of the WHO and UNICEF estimates of national immunization coverage: a computational logic approach. *Brown et al An introduction to the grade of confidence used to characterize uncertainty around the WHO and UNICEF estimates of national immunization coverage. DATA SOURCES. ADMINISTRATIVE coverage: Reported by national authorities and based on aggregated administrative reports from health service providers on the number of vaccinations administered during a given period (numerator data) and reported target population data (denominator data). May be biased by inaccurate numerator and/or denominator data. OFFICIAL coverage: Estimated coverage reported by national authorities that reflects their assessment of the most likely coverage based on any combination of administrative coverage, survey-based estimates or other data sources or adjustments. Approaches to determine OFFICIAL coverage may differ across countries. SURVEY coverage: Based on estimated coverage from population-based household surveys among children aged months or months following a review of survey methods and results. Information is based on the combination of vaccination history from documented evidence or caregiver recall. Survey results are considered for the appropriate birth cohort based on the period of data collection. ABBREVIATIONS BCG: percentage of births who received one dose of Bacillus Calmette Guerin vaccine. DTP1 / DTP3: percentage of surviving infants who received the 1st / 3rd dose, respectively, of diphtheria and tetanus toxoid with pertussis containing vaccine. Pol3: percentage of surviving infants who received the 3rd dose of polio containing vaccine. May be either oral or inactivated polio vaccine. IPV1: percentage of surviving infants who received at least one dose of inactivated polio vaccine. In countries utilizing an immunization schedule recommending either (i) a primary series of three doses of oral polio vaccine (OPV) plus at least one dose of IPV where OPV is included in routine immunization and/or campaign or (ii) a sequential schedule of IPV followed by OPV, WHO and UNICEF estimates for IPV1 reflect coverage with at least one routine dose of IPV among infants <1 year of age among countries. For countries utilizing IPV containing vaccine use only, i.e., no recommended dose of OPV, the WHO and UNICEF estimate for IPV1 corresponds to coverage for the 1st dose of IPV. Production of IPV coverage estimates, which begins in 2015, results in no change of the estimated coverage levels for the 3rd dose of polio (Pol3). For countries recommending routine immunization with a primary series of three doses of IPV alone, WHO and UNICEF estimated Pol3 coverage is equivalent to estimated coverage with three doses of IPV. For countries with a sequential schedule, estimated Pol3 coverage is based on that for the 3rd dose of polio vaccine regardless of vaccine type. MCV1: percentage of surviving infants who received the 1st dose of measles containing vaccine. In countries where the national schedule recommends the 1st dose of MCV at 12 months or later based on the epidemiology of disease in the country, coverage estimates reflect the percentage of children who received the 1st dose of MCV as recommended. MCV2: percentage of children who received the 2nd dose of measles containing vaccine according to the nationally recommended schedule. RCV1: percentage of surviving infants who received the 1st dose of rubella containing vaccine. Co verage estimates are based on WHO and UNICEF estimates of coverage for the dose of measles containing vaccine that corresponds to the first measles-rubella combination vaccine. Nationally reported coverage of RCV is not taken into consideration nor are the data represented in the accompanying graph and data table. HepBB: percentage of births which received a dose of hepatitis B vaccine within 24 hours of delivery. Estimates of hepatitis B birth dose coverage are produced only for countries with a universal birth dose policy. Estimates are not produced for countries that recommend a birth dose to infants born to HepB virus-infected mothers only or where there is insufficient information to determine whether vaccination is within 24 hours of birth. HepB3: percentage of surviving infants who received the 3rd dose of hepatitis B containing vaccine following the birth dose. Hib3: percentage of surviving infants who received the 3rd dose of Haemophilus influenzae type b containing vaccine. RotaC: percentage of surviving infants who received the final recommended dose of rotavirus vaccine, which can be either the 2nd or the 3rd dose depending on the vaccine. PcV3: percentage of surviving infants who received the 3rd dose of pneumococcal conjugate vaccine. In countries where the national schedule recommends two doses during infancy and a booster dose at 12 months or later based on the epidemiology of disease in the country, coverage estimates may reflect the percentage of surviving infants who received two doses of PcV prior to the 1st birthday. YFV: percentage of surviving infants who received one dose of yellow fever vaccine in countries where YFV is part of the national immunization schedule for children or is recommended in at risk areas; coverage estimates are annualized for the entire cohort of surviving infants. Disclaimer: All reasonable precautions have been taken by the World Health Organization and United Nations Children s Fund to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization or United Nations Children s Fund be liable for damages arising from its use. July 7, 2018; page 2 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
3 Nigeria - BCG Description: Estimate Estimate GoC Official 42 NA 62 NA Administrative NA NA 96 Survey NA NA 51 NA NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. 2017: Estimate is based on results of the 2016 MICS-NICS survey. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. Programme reports national level stock-out of unspecified duration. Estimate challenged by: D- 2016: Estimate of 53 percent assigned by working group. Estimate is based on results of the 2016 MICS-NICS survey. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 53 percent changed from previous revision value of 64 percent. Estimate challenged by: D- 2015: Estimate of 53 percent assigned by working group. Estimate is based on results of the 2016 MICS-NICS survey. Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. Reported official government estimate received July 2017 is based on preliminary 2016 MICS-NICS results applied to the 2015 birth cohort. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 53 percent changed from previous revision value of 64 percent. Estimate challenged by: D- 2014: Estimate of 51 percent assigned by working group. Estimate based on results from the 2016 MICS-NICS survey. Reported data excluded. Official government estimate based on an adjustment to the administrative data based on a correction factor of 75 percent that was derived from observation of a community survey showing that 69 percent of infants were fully vaccinated. Nearly three-quarters of community survey respondents were from northern states observed to have lower routine immunization coverage. Estimate of 51 percent changed from previous revision value of 64 percent. Estimate challenged by: D-R- 2013: Reported data calibrated to 2012 and 2014 levels. Reported data excluded. Official government estimate based on administrative data adjusted the mean between using a 2014 DQS verification factor and results from a community survey. Estimate of 51 percent changed from previous revision value of 57 percent. Estimate challenged by: D-R- 2012: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 51 percent based on 1 survey(s). Reported data excluded due to an increase from 60 percent to 87 percent with decrease 69 percent. Estimate challenged by: D-R-S- 2011: Estimate based on interpolation between 2010 and 2012 levels. Estimate based on interpolated value between 2010 and 2012 survey values Reported data excluded due to decline in reported coverage from 76 percent to 60 percent with increase to 87 percent. Estimate based on level established by the 2009 survey and follows trend in the reported data. Nigeria cites shortages of some vaccines and injection supplies (stock-out of AD syringes for 252 days), repeated health worker strike actions and security challenges in several northern states. The vaccine stock outs were due in part to the late release of funds July 7, 2018; page 3 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
4 Nigeria - BCG for routine immunization in July 2012 and reallocation of routine immunization vaccine funds to other priorities (measles and polio campaigns) (2012 Nigeria GAVI progress report for 2011). Estimate challenged by: R-S- 2010: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 62 percent based on 1 survey(s). Estimate based on level established by the 2009 survey and follows trend in the reported data. Survey results support the trends but not the coverage levels intertemporally and across vaccines. Estimate challenged by: D-R-S- 2009: Estimate of 76 percent assigned by working group. Estimate based on survey results. Survey suggests that 60 percent of immunization services are obtained from fixed sites. Estimate challenged by: R-S- 2008: Reported data calibrated to 2007 and 2009 levels. Reported data excluded. Estimates based on survey results. Fluctuations in reported data suggest poor quality administrative recording and reporting. Estimate challenged by: R-S- 2007: Estimate based on administrative data reported by national government supported by survey. Survey evidence of 50 percent based on 1 survey(s). Estimate challenged by: S- 2006: Estimate of 52 percent assigned by working group. Estimates based on survey results. Fluctuations in reported data suggest poor quality administrative recording and reporting. Estimate challenged by: D-R- July 7, 2018; page 4 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
5 Nigeria - DTP1 Description: Estimate Estimate GoC Official 87 NA 66 NA Administrative NA NA 114 Survey NA NA * NA * 49 NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. 2017: Estimate is based on survey results. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. Estimate challenged by: D- 2016: Estimate of 49 percent assigned by working group. Estimate is based on survey results. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 49 percent changed from previous revision value of 64 percent. Estimate challenged by: D- 2015: Estimate of 49 percent assigned by working group. Estimate is based on survey results. Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 49 percent changed from previous revision value of 64 percent. Estimate challenged by: D- 2014: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 48 percent based on 1 survey(s). Nigeria National Nutrition and Health Survey, 2015 results ignored by working group. The results of the 2015 Nigeria National Nutrition and Health Survey are presented such that coverage by card and by recall cannot be assessed and thus are not considered.reported data excluded. Official government estimate based on an adjustment to the administrative data based on a correction factor of 75 percent that was derived from observation of a community survey showing that 69 percent of infants were fully vaccinated. Nearly three-quarters of community survey respondents were from northern states observed to have lower routine immunization coverage. Estimate of 48 percent changed from previous revision value of 64 percent. Estimate challenged by: D-R- 2013: Reported data calibrated to 2012 and 2014 levels. Reported data excluded. Official government estimate based on administrative data adjusted the mean between using a 2014 DQS verification factor and results from a community survey. Administrative data documents recovery from pentavalent DTP-HepB-Hib and MCV stockout. Estimate of 49 percent changed from previous revision value of 58 percent. Estimate challenged by: D-R- 2012: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 51 percent based on 1 survey(s). Summary Findings of Cross-Sectional Health and Nutrition Survey, Nigeria 2013 results ignored by working group. Survey is ignored because it is a sub-national survey conducted in twenty-four states, accounting for approximately sixty-four percent of national target population. DTP-HepB-Hib pentavalent vaccine introduced in Estimate challenged by: D-R- 2011: Reported data calibrated to 2010 and 2012 levels. Reported data excluded.. Estimate based on level established by the 2009 survey and follows trend in the reported data. July 7, 2018; page 5 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
6 Nigeria - DTP1 Nigeria cites shortages of some vaccines and injection supplies (stock-out of AD syringes for 252 days), repeated health worker strike actions and security challenges in several northern states. The vaccine stock outs were due in part to the late release of funds for routine immunization in July 2012 and reallocation of routine immunization vaccine funds to other priorities (measles and polio campaigns) (2012 Nigeria GAVI progress report for 2011). Estimate challenged by: D-R-S- 2010: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 60 percent based on 1 survey(s). Estimate based on level established by the 2009 survey and follows trend in the reported data. Survey results support the trends but not the coverage levels intertemporally and across vaccines. Estimate challenged by: D-R-S- 2009: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 73 percent based on 1 survey(s). Survey suggests that 60 percent of immunization services are obtained from fixed sites. Estimate challenged by: D-R-S- 2008: Reported data calibrated to 2007 and 2009 levels. Reported data excluded due to decline in reported coverage from 77 percent to 66 percent with increase to 91 percent. Estimate challenged by: D-R-S- 2007: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 52 percent based on 1 survey(s). Estimate challenged by: D-R-S- 2006: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 49 percent based on 1 survey(s). Estimate challenged by: D-R- July 7, 2018; page 6 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
7 Nigeria - DTP3 Description: Estimate Estimate GoC Official 72 NA 57 NA Administrative NA NA 106 Survey NA NA * NA * 34 NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. 2017: Reported data calibrated to 2015 levels. Reported data excluded because 106 percent greater than 100 percent. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. The reported government official estimate is based on results from the 2016 MICS-NICS survey, however, the official estimate does not account for recall bias. Estimate challenged by: D-R- 2016: Reported data calibrated to 2015 levels. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 49 percent. Estimate challenged by: D- 2015: Estimate of 42 percent assigned by working group. Estimate is based on survey results. Nigeria Multiple Indicator Cluster Survey card or history results of 34 percent modifed for recall bias to 42 percent based on 1st dose card or history coverage of 49 percent, 1st dose card only coverage of 27 percent and 3rd dose card only coverage of 23 percent. Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 49 percent. Estimate challenged by: D- 2014: Estimate of 43 percent assigned by working group. Estimate is based on survey coverage level. Nigeria National Nutrition and Health Survey, 2015 results ignored by working group. The results of the 2015 Nigeria National Nutrition and Health Survey are presented such that recall bias cannot be assessed and thus are not considered.nigeria Multiple Indicator Cluster Survey card or history results of 32 percent modifed for recall bias to 43 percent based on 1st dose card or history coverage of 48 percent, 1st dose card only coverage of 18 percent and 3rd dose card only coverage of 16 percent. Reported data excluded. Official government estimate based on an adjustment to the administrative data based on a correction factor of 75 percent that was derived from observation of a community survey showing that 69 percent of infants were fully vaccinated. Nearly three-quarters of community survey respondents were from northern states observed to have lower routine immunization coverage. Estimate of 43 percent changed from previous revision value of 49 percent. Estimate challenged by: D-R- 2013: Reported data calibrated to 2012 and 2014 levels. Reported data excluded. Official government estimate based on administrative data adjusted the mean between using a 2014 DQS verification factor and results from a community survey. Administrative data documents recovery from pentavalent DTP-HepB-Hib and MCV stockout. Estimate of 43 percent changed from previous revision value of 46 percent. Estimate challenged by: D-R- 2012: Survey evidence does not support reported data. Estimate based on survey results. Sur- July 7, 2018; page 7 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
8 Nigeria - DTP3 vey evidence of 42 percent based on 1 survey(s). Summary Findings of Cross-Sectional Health and Nutrition Survey, Nigeria 2013 results ignored by working group. Survey is ignored because it is a sub-national survey conducted in twenty-four states, accounting for approximately sixty-four percent of national target population.nigeria Demographic and Health Survey 2013 card or history results of 38 percent modifed for recall bias to 42 percent based on 1st dose card or history coverage of 51 percent, 1st dose card only coverage of 27 percent and 3rd dose card only coverage of 22 percent. DTP-HepB-Hib pentavalent vaccine introduced in Estimate challenged by: D-R-S- 2011: Estimate based on interpolation between 2010 and 2012 levels. Estimate based on interpolated value between 2010 and 2012 survey values Estimate based on level established by the 2009 survey and follows trend in the reported data. Nigeria cites shortages of some vaccines and injection supplies (stock-out of AD syringes for 252 days), repeated health worker strike actions and security challenges in several northern states. The vaccine stock outs were due in part to the late release of funds for routine immunization in July 2012 and reallocation of routine immunization vaccine funds to other priorities (measles and polio campaigns) (2012 Nigeria GAVI progress report for 2011). Estimate challenged by: D-R-S- 2010: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 54 percent based on 1 survey(s). Nigeria Multiple Indicator Cluster Survey 2011 card or history results of 45 percent modifed for recall bias to 54 percent based on 1st dose card or history coverage of 60 percent, 1st dose card only coverage of 29 percent and 3rd dose card only coverage of 26 percent. Estimate based on level established by the 2009 survey and follows trend in the reported data. Survey results support the trends but not the coverage levels intertemporally and across vaccines. Estimate challenged by: D-R-S- 2009: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 63 percent based on 1 survey(s). Nigeria 2010 National Immunization Coverage Survey card or history results of 68 percent modifed for recall bias to 63 percent based on 1st dose card or history coverage of 73 percent, 1st dose card only coverage of 29 percent and 3rd dose card only coverage of 25 percent. Survey suggests that 60 percent of immunization services are obtained from fixed sites. Estimate challenged by: D-R-S- 2008: Reported data calibrated to 2007 and 2009 levels. Reported data excluded due to decline in reported coverage from 69 percent to 57 percent with increase to 79 percent. Estimate challenged by: D-R-S- 2007: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 42 percent based on 1 survey(s). Nigeria Demographic and Health Survey 2008 card or history results of 35 percent modifed for recall bias to 42 percent based on 1st dose card or history coverage of 52 percent, 1st dose card only coverage of 25 percent and 3rd dose card only coverage of 20 percent. Estimate challenged by: D-R-S- 2006: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 40 percent based on 1 survey(s). Nigeria Multiple Indicator Cluster Survey 2007 card or history results of 30 percent modifed for recall bias to 40 percent based on 1st dose card or history coverage of 49 percent, 1st dose card only coverage of 17 percent and 3rd dose card only coverage of 14 percent. Reported data excluded. Includes data from supplementary immunization activities (CHD) Estimate challenged by: D-R- July 7, 2018; page 8 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
9 Nigeria - Pol3 Description: Estimate Estimate GoC Official 67 NA 50 NA Administrative NA NA 106 Survey NA NA 54 NA NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. 2017: Estimate of 40 percent assigned by working group. Estimate is based on survey result adjusted for recall bias. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. Estimate challenged by: D-R- 2016: Estimate of 40 percent assigned by working group. Estimate is based on survey result adjusted for recall bias. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 40 percent changed from previous revision value of 49 percent. Estimate challenged by: D- 2015: Estimate of 40 percent assigned by working group. Estimate is based on survey result adjusted for recall bias. Nigeria Multiple Indicator Cluster Survey card or history results of 35 percent modifed for recall bias to 40 percent based on 1st dose card or history coverage of 50 percent, 1st dose card only coverage of 26 percent and 3rd dose card only coverage of 21 percent. Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS- NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 40 percent changed from previous revision value of 49 percent. Estimate challenged by: D- 2014: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 40 percent based on 1 survey(s). Nigeria Multiple Indicator Cluster Survey card or history results of 30 percent modifed for recall bias to 40 percent based on 1st dose card or history coverage of 48 percent, 1st dose card only coverage of 17 percent and 3rd dose card only coverage of 14 percent. Reported data excluded. Official government estimate based on an adjustment to the administrative data based on a correction factor of 75 percent that was derived from observation of a community survey showing that 69 percent of infants were fully vaccinated. Nearly three-quarters of community survey respondents were from northern states observed to have lower routine immunization coverage. Estimate of 40 percent changed from previous revision value of 49 percent. Estimate challenged by: D-R- 2013: Reported data calibrated to 2012 and 2014 levels. Reported data excluded. Official government estimate based on administrative data adjusted the mean between using a 2014 DQS verification factor and results from a community survey. Estimate of 41 percent changed from previous revision value of 46 percent. Estimate challenged by: D-R- 2012: Estimate of 42 percent assigned by working group. Estimate based on survey result adjusted for recall bias for third dose of DTP containing vaccine. Survey result for polio for 2010 birth cohort ignored due to likely inclusion of campaign doses. Nigeria Demographic and Health Survey 2013 results ignored by working group. Survey result for polio vaccine likely includes campaign doses due to reliance on caregiver recall in face of low retention of home-based records.nigeria Demographic and Health Survey 2013 card or July 7, 2018; page 9 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
10 Nigeria - Pol3 history results of 54 percent modifed for recall bias to 65 percent based on 1st dose card or history coverage of 76 percent, 1st dose card only coverage of 27 percent and 3rd dose card only coverage of 23 percent. Estimate challenged by: D-R- 2011: Estimate based on interpolation between 2010 and 2012 levels. Estimate is based on htird dose of DTP containing vaccine. Estimate based on level established by the 2009 survey and follows trend in the reported data. Nigeria cites shortages of some vaccines and injection supplies (stock-out of AD syringes for 252 days), repeated health worker strike actions and security challenges in several northern states. The vaccine stock outs were due in part to the late release of funds for routine immunization in July 2012 and reallocation of routine immunization vaccine funds to other priorities (measles and polio campaigns) (2012 Nigeria GAVI progress report for 2011). Estimate challenged by: D-R-S- 2010: Estimate of 54 percent assigned by working group. Estimate is based on DTP3 levels. Nigeria Multiple Indicator Cluster Survey 2011 results ignored by working group. Survey results likely include campaign doses.nigeria Multiple Indicator Cluster Survey 2011 card or history results of 49 percent modifed for recall bias to 68 percent based on 1st dose card or history coverage of 76 percent, 1st dose card only coverage of 28 percent and 3rd dose card only coverage of 25 percent. Estimate based on level established by the 2009 survey and follows trend in the reported data. Survey results support the trends but not the coverage levels intertemporally and across vaccines. Estimate challenged by: D-R-S- 2009: Estimate of 66 percent assigned by working group. Estimate based on survey results. Nigeria 2010 National Immunization Coverage Survey card or history results of 74 percent modifed for recall bias to 66 percent based on 1st dose card or history coverage of 78 percent, 1st dose card only coverage of 27 percent and 3rd dose card only coverage of 23 percent. Survey suggests that 60 percent of immunization services are obtained from fixed sites. Estimate challenged by: R-S- 2008: Reported data calibrated to 2007 and 2009 levels. Reported data excluded due to decline in reported coverage from 62 percent to 50 percent with increase to 70 percent. Estimate challenged by: R-S- 2007: Estimate of 54 percent assigned by working group. Anchor point resolved to survey data. Fluctuations in reported data suggest poor quality administrative recording and reporting. Nigeria Demographic and Health Survey 2008 card or history results of 39 percent modifed for recall bias to 54 percent based on 1st dose card or history coverage of 68 percent, 1st dose card only coverage of 24 percent and 3rd dose card only coverage of 19 percent. Estimate challenged by: R-S- 2006: Estimate of 46 percent assigned by working group. Anchor point resolved to survey data. Fluctuations in reported data suggest poor quality administrative recording and reporting. Nigeria Multiple Indicator Cluster Survey 2007 card or history results of 29 percent modifed for recall bias to 46 percent based on 1st dose card or history coverage of 56 percent, 1st dose card only coverage of 16 percent and 3rd dose card only coverage of 13 percent. Estimate challenged by: R- July 7, 2018; page 10 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
11 Nigeria - IPV1 Description: Estimates for a dose of IPV begin in 2015 following the Global Polio Eradication Initiative s Polio Eradication and Endgame Strategic Plan: which recommended at least one dose of inactivated polio vaccine (IPV) into routine immunization schedules as a strategy to mitigate the potential consequences should any re-emergence of type 2 poliovirus occur following the planned withdrawal of Sabin type 2 strains from oral polio vaccine (OPV) Estimate NA NA NA NA NA NA NA NA NA Estimate GoC NA NA NA NA NA NA NA NA NA Official NA NA NA NA NA NA NA NA NA NA Administrative NA NA NA NA NA NA NA NA NA NA NA 100 Survey NA NA NA NA NA NA NA NA NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. 2017: Reported data calibrated to 2015 levels. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. Estimate is based on results of the 2016 MICS-NICS survey. Estimate challenged by: D-R- 2016: Reported data calibrated to 2015 levels. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Estimate is based on results of the 2016 MICS-NICS survey. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 49 percent. Estimate challenged by: D- 2015: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 42 percent based on 1 survey(s). Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. IPV introduced in early Government reports an exceptionally high year-to-year increase in the number of surviving infants compared to the UN Population Division. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 30 percent. Estimate challenged by: D- Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. July 7, 2018; page 11 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
12 Nigeria - MCV1 Description: Estimate Estimate GoC Official 112 NA 68 NA Administrative NA NA 104 Survey NA NA * NA * 42 NA NA The WHO and UNICEF estimates of national immunization coverage (wuenic) are based on data and information that are of varying, and, in some instances, unknown quality. Beginning with the 2011 revision we describe the grade of confidence (GoC) we have in these estimates. As there is no underlying probability model upon which the estimates are based, we are unable to present classical measures of uncertainty, e.g., confidence intervals. Moreover, we have chosen not to make subjective estimates of plausibility/certainty ranges around the coverage. The GoC reflects the degree of empirical support upon which the estimates are based. It is not a judgment of the quality of data reported by national authorities. Estimate is supported by reported data [R+], coverage recalculated with an independent denominator from the World Population Prospects: 2017 revision from the UN Population Division (D+), and at least one supporting survey within 2 years [S+]. While well supported, the estimate still carries a risk of being wrong. Estimate is supported by at least one data source; [R+], [S+], or [D+]; and no data source, [R-], [D-], or [S-], challenges the estimate. There are no directly supporting data; or data from at least one source; [R-], [D-], [S-]; challenge the estimate. In all cases these estimates should be used with caution and should be assessed in light of the objective for which they are being used. 2017: Estimate based on results of the 2016 MICS-NICS survey. WHO and UNICEF encourage a comprehensive review and revision of the historical time-series of reported coverage data. Estimate challenged by: D- 2016: Estimate of 42 percent assigned by working group. Estimate based on results of the 2016 MICS-NICS survey. Programme reports district level vaccine supply disruptions for all vaccines in the infant immunization series. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 51 percent. Estimate challenged by: D- 2015: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 42 percent based on 1 survey(s). Programme acknowledges challenges in data quality impacting on administrative coverage levels, including delays and incomplete reporting. Official estimates for 2015 are based on preliminary survey results from the 2016 MICS-NICS survey. Final survey results became available in late 2017 and differed slightly from preliminary results. Estimate of 42 percent changed from previous revision value of 51 percent. Estimate challenged by: D- 2014: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 44 percent based on 1 survey(s). Nigeria National Nutrition and Health Survey, 2015 results ignored by working group. The results of the 2015 Nigeria National Nutrition and Health Survey are presented such that coverage by card and by recall cannot be assessed and thus are not considered.reported data excluded. Official government estimate based on an adjustment to the administrative data based on a correction factor of 75 percent that was derived from observation of a community survey showing that 69 percent of infants were fully vaccinated. Nearly three-quarters of community survey respondents were from northern states observed to have lower routine immunization coverage. Estimate of 44 percent changed from previous revision value of 51 percent. Estimate challenged by: D-R- 2013: Reported data calibrated to 2012 and 2014 levels. Reported data excluded. Official government estimate based on administrative data adjusted the mean between using a 2014 DQS verification factor and results from a community survey. Administrative data documents recovery from pentavalent DTP-HepB-Hib and MCV stockout. Estimate of 43 percent changed from previous revision value of 46 percent. Estimate challenged by: D-R- 2012: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 42 percent based on 1 survey(s). Summary Findings of Cross-Sectional Health and Nutrition Survey, Nigeria 2013 results ignored by working group. Survey is ignored because it is a sub-national survey conducted in twenty-four states, accounting for approximately sixty-four percent of national target population. Estimate challenged by: D-R-S- 2011: Estimate based on interpolation between 2010 and 2012 levels. Estimate based on interpo- July 7, 2018; page 12 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
13 Nigeria - MCV1 lated value between 2010 and 2012 survey values Estimate based on level established by the 2009 survey and follows trend in the reported data. Nigeria cites shortages of some vaccines and injection supplies (stock-out of AD syringes for 252 days), repeated health worker strike actions and security challenges in several northern states. The vaccine stock outs were due in part to the late release of funds for routine immunization in July 2012 and reallocation of routine immunization vaccine funds to other priorities (measles and polio campaigns) (2012 Nigeria GAVI progress report for 2011). Estimate challenged by: D-R-S- 2010: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 56 percent based on 1 survey(s). Estimate based on level established by the 2009 survey and follows trend in the reported data. Survey results support the trends but not the coverage levels intertemporally and across vaccines. Estimate challenged by: D-R-S- 2009: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 64 percent based on 1 survey(s). Survey suggests that 60 percent of immunization services are obtained from fixed sites. Estimate challenged by: D-R-S- 2008: Reported data calibrated to 2007 and 2009 levels. Reported data excluded due to decline in reported coverage from 86 percent to 68 percent with increase to 90 percent. Estimate challenged by: D-R-S- 2007: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 41 percent based on 1 survey(s). Estimate challenged by: D-R-S- 2006: Survey evidence does not support reported data. Estimate based on survey results. Survey evidence of 44 percent based on 1 survey(s). Reported data excluded because 112 percent greater than 100 percent. Reported data excluded due to an increase from 38 percent to 112 percent with decrease 86 percent. Estimate challenged by: D-R- July 7, 2018; page 13 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received as of July 4, 2018
Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data
WHITE PAPER. A Summary of Global Immunization Coverage through David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order)
WHITE PAPER A Summary of Global Immunization Coverage through 2013 David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order) for the WHO and UNICEF working group for monitoring national immunization
GLOBAL IMMUNIZATION COVERAGE IN 2016
NATIONAL IMMUNIZATION COVERAGE SCORECARDS ESTIMATES FOR 2016 GLOBAL IMMUNIZATION COVERAGE IN 2016 In May 2012, the Sixty-fifth World Health Assembly endorsed the Global Vaccine Action Plan (GVAP) for the
Expanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)
Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region
Expanded Programme on Immunization (EPI)
Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing
Selected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
Expanded Programme on Immunization (EPI)
Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
WHO/UNICEF Review of National Immunization Coverage India
WHO/UNICEF Review of National Immunization Coverage 1980-2002 India October, 2003 India Estimates, 1980-2002 80 66 68 73 73 60 40 30 20 10 0 1980 19 1982 1983 1984 1985 1986 1987 1988 1989 19 1991 1992
Expanded Programme on Immunization (EPI)
Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,
LESSONS FROM THE FIELD
LESSONS FROM THE FIELD Recording errors in homemade home-based records to record vaccination services: results from the 2016 Kenya Missed Opportunities for Vaccination Assessment David W. BROWN, Collins
Overview of WHO/UNICEF Immunization Coverage Estimates
Overview of WHO/UNICEF Immunization Coverage Estimates Marta Gacic-Dobo, Anthony Burton, David Durrheim Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 8-10 November 2011 CCV/CICG,
Current National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.
Current National Immunisation Schedule 2012 Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake rates School
The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
Immunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
National HPV Vaccine Coverage, WHO- UNICEF Joint Reporting Form
resource from : Evaluating HPV vaccination pilots: practical experience from path publication title National HPV Vaccine Coverage, WHO- UNICEF Joint Reporting Form publisher WHO/UNICEF publication date
Exercise: Estimating immunization program costs (~60 minutes)
Exercise: Estimating immunization program costs (~60 minutes) Overview Information on the cost of procuring vaccines and of running national immunization program is a key factor in planning and managing
Pertussis. (Whole-cell pertussis vaccines) must not be frozen, but stored at 2 8 C. All wp vaccines have an expiry date of months.
Program Management 61_5 The wp vaccines have a considerably lower price than ap vaccines and, where resources are limited and the vaccine is well accepted by the local population, wp vaccine remains the
within three to six months of the launch of a new vaccine.
Gavi Full Country Evaluations Findings Summary of recommendations General Provide short and succinct reference materials for new vaccines to health workers rather than wait for the National Immunization
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
immunisation in New Zealand
This appendix details the history of. Section A1.1 is a brief summary of when each vaccine was introduced to the National Immunisation Schedule (the Schedule). This summary includes vaccines which were
VACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
Appendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
Challenges of building a new vaccine delivery platform for LMICs
Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
Role of Partnerships in Developing Innovative Vaccines: Brazil
Role of Partnerships in Developing Innovative Vaccines: Brazil SAGE Meeting, October 2010 Reinaldo Guimarães, M.D, MSc. Secretary of Science, Technology and Strategic Inputs Ministry of Health of Brazil
Government of Bangladesh
Gavi Full Country Evaluations Findings Summary of recommendations Expanded Programme on Immunization Government of Gavi Secretariat With country-level partners, target efforts on low coverage areas and
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
Table 1: Basic information 2017
EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB
Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central
Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.
Vaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
Healthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
Global landscape analysis and literature review of 2 nd Year of Life immunization platform
Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina
Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
Immunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
Immunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
Utah s Immunization Rule Individual Vaccine Requirements
Utah s Immunization Rule Individual Vaccine Requirements Which vaccines are required for school entry in Utah? Grades K-6: 5 doses DTaP (4 doses if the 4 th dose was given after the 4 th birthday) 4 doses
Summary of Definitions of Mission and Strategic Goal Level Indicators. in GAVI Alliance Strategy Updated October 2013
Summary of s of Mission and Strategic Goal Level Indicators in GAVI Alliance Strategy 2011-2015 Updated October 2013 Table of Contents Under five mortality rate ------------------------------------------------------------------------------------------------------------------------
Evaluating Immunisation Dropout Rates in Eight Hard to Reach Unions of Maulvibazar District, Bangladesh
International Journal of Immunology 2017; 5(1): 5-10 http://www.sciencepublishinggroup.com/j/iji doi: 10.11648/j.iji.20170501.12 ISSN: 2329-177X (Print); ISSN: 2329-1753 (Online) Evaluating Immunisation
GAVI Role in IPV Introductions
GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported
Manitoba Health, Healthy Living and Seniors
Manitoba Health, Healthy Living and Seniors Manitoba Annual Immunization Surveillance Report, 2012 and 2013 January 1, 2012 to December 31, 2013 with 5-year average comparison (January 1, 2007 to December
Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210
EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine
UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013
UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013 Presentation overview Scope of UNICEF procurement Overview of UNICEF procurement Vaccine market updates UNICEF procures
VERSION APPROVAL PROCESS NUMBER 1.0 Nina Schwalbe, Managing Director, Policy and Performance
Version No.: 1.0 Page 1 / 5 DOCUMENT ADMINISTRATION VERSION APPROVAL PROCESS DATE NUMBER 1.0 Nina Schwalbe, Managing Director, and Performance Reviewed by: GAVI Programme 23 April 2012 and Committee Approved
CHILDHOOD VACCINATION
EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,
Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.
EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced
The Johns Hopkins Vaccine Initiative Johns Hopkins Bloomberg School of Public Health
WHO Internships (Terms of Reference) for VIEW Scholars Program January 2010 A. Examining approaches to collecting and analyzing HPV vaccine coverage data B. County level burden of disease estimates for
Daycare, school entry and school program immunization report September Data for school years 2012/13 to 2014/15
Daycare, school entry and school program immunization report September 2015 Data for school years 2012/13 to 2014/15 Table of Contents Contents 1. Introduction... 0 2. Data Source... 1 3. Limitations...
The National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake
WHY WE RE HERE. Melinda Wharton, MD, MPH Director, Immunization Services Division. National Center for Immunization & Respiratory Diseases
National Center for Immunization & Respiratory Diseases WHY WE RE HERE Melinda Wharton, MD, MPH Director, Immunization Services Division AIM Leadership Conference February 8, 2017 Vaccines save lives.
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
Targeted Diseases and Immunization. Strategic plan
Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure
Global Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries : Evidence from the First Phase of GAVI (Global Alliance for Vaccines and Immunization) Patrick Lydon lydonp@who.int Session:
The National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office : Dates vaccines introduced into the Irish immunisation schedule Vaccine 1937-1999 Date introduced
This document was published by: The National Department of Health. Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo
REVISED : OCTOBER 2010 This document was published by: The National Department of Health Editorial team: Provincial EPI Team National EPI Team Dr NJ Ngcobo Copies may be obtained from: The National Department
Immunization Guidelines for the Use of State Supplied Vaccine April 18, 2013
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
Requirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.
Requirements for new trials to examine offtarget effects of vaccination Workshop on: Off-target (heterologous/non-specific) effects of vaccination Les Pensieres Jun 8-10, 2015 PEM Fine London School of
Adolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
VI Child Health. Immunisation
VI Child Health Immunisation Millennium Development Goal (MDG) 4 is to reduce child mortality by two-thirds between 1990 and 2015. Immunisation plays a key part in this goal. Immunisation has saved the
Global Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
History and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
Changes for the School Year. The addition of NINTH grade to the requirement for four (4) doses of diphtheria, tetanus, and pertussis.
February 19, 2013 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and State Regulation 61-8, the 2013-2014 "Required Standards of Immunization for School
Establishing a second-year-of-life (2YL) healthy child visit
Establishing a second-year-of-life (2YL) healthy child visit Dr Rudi Eggers Presentation to the Global Vaccines and Immunization Research Forum Sandton, 15 March 2016 Session Objectives Provide an overview
NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11
NHS GRAMPIAN IMMUNISATION PROGRAMMES ANNUAL REPORT 2010/11 NHS GRAMPIAN IMMUNISATION STEERING GROUP March 2012 1 Table of Content 1. Purpose of this report.3 2. Uptake of immunisation: key points during
The National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake
Ministry of health. Our Community
Ministry of health Our Community This flip book is specially developed for Community Health Volunteer CHVs MUST ask 4 questions while using communication materials 1. What is happening in this picture?
RECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
GAVI S VACCINE INVESTMENT STRATEGY
GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in
used for HPV vaccine delivery to identify best practices and inform efforts to improve HPV vaccine coverage nationwide.
Gavi Full Country Evaluations Findings Summary of recommendations Ministry of Finance» Be involved at all stages of planning for new vaccine introductions. Ministry of Health» Conduct a survey to fully
The National Immunisation Schedule Update and Current issues November Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues November 2013 Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule
School Nurse Regional Update School Year Immunizations COLORADO IMMUNIZATION BRANCH
School Nurse Regional Update 2017-18 School Year Immunizations COLORADO IMMUNIZATION BRANCH Talking Points Child Care Immunizations K through 12 th Grade Immunizations Official Medical and Non-Medical
Communicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
Daycare, school entry and school program immunization report. Data for school year 2016/17
Daycare, school entry and school program immunization report Data for school year 2016/17 Table of Contents 1. Introduction... 1 2. Data Source... 1 3. Limitations... 2 4. Daycare - Proof of Immunization...
Cyprus Experience. Dr. Elena Papamichael Ministry of Health
Cyprus Experience Dr. Elena Papamichael Ministry of Health Cyprus became independent on1960. On 1974, Turkish troops invaded in the island disturbing the willing for peaceful living. Since then, Turkey
Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
BCG. Program Management. Vaccine Quality
Program Management 50_16 To change from general to selective BCG vaccination, an efficient notification system must be in place in addition to the following criteria: an average annual notification rate
Schools. Kindergarten
1 of 5 7/29/2014 4:14 PM Schools North Carolina law requires all children in the state to receive certain immunizations. Records are checked when children enter school or child care. Kindergarten Vaccination
Daycare, school entry and school program immunization report. Data for school year 2015/16
Daycare, school entry and school program immunization report Data for school year 2015/16 Table of Contents Table of Content2 1. Introduction... 1 2. Data Source... 1 3. Limitations... 2 4. Daycare - Proof
Last mile vaccine distribution to rural health centres. Faheem Merchant
Last mile vaccine distribution to rural health centres Faheem Merchant New Global Immunization Goals 2000 - Millennium Development Goal # 4 Reduce under 5 child mortality by 2/3 between 1990 and 2015.
Immunization Guidelines For the Use of State Supplied Vaccine July 1, 2011
DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,
Routine Immunization Schedules. Section 2. Newfoundland and Labrador Immunization Manual. Routine Immunization Schedules
Newfoundland and Labrador Immunization Manual Section 2... 2.1 Routine and Delayed Immunization Schedules for Infants and Children... 2.2 Recommended Immunizations for Adults... 2.3 (Provinces and Territories)...
Preventing Vaccine-Preventable Diseases in HIV-Infected Children and Adults
Preventing Vaccine-Preventable Diseases in HIV-Infected Children and Adults 1. Objective The objectives of this chapter are to underline the role of vaccination in reducing morbidity and mortality in HIV
Table 1. Primary childhood immunisation schedule for children born between 01/07/2008 and 30/06/2015
ackground The national immunisation uptake statistics, based on available data, for Quarter 1 2015 are presented in this report. These immunisation uptake statistics relate to children at 12 (born between
WHO Library Cataloguing-in-Publication Data. World health statistics 2011.
WORLD HEALTH STATISTICS 2011 WHO Library Cataloguing-in-Publication Data World health statistics 2011. 1.Health status indicators. 2.World health. 3.Health services - statistics. 4.Mortality. 5.Morbidity.
Immunization Records. childrens.memorialhermann.org CARE /13
Immunization Records childrens.memorialhermann.org 713.222.CARE 4400209-4/13 Personal Health Record of The Woodlands Contact Information Date and time of birth Place of birth Pediatrician name, phone number
What DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
Manitoba Annual Immunization Surveillance Report
Annual Immunization Surveillance Report January 1 to December 31, 2014 Epidemiology & Surveillance Public Branch Public and Primary Care Division, y Living and Seniors Released: January 2016 TABLE OF CONTENTS
Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016
Update on Transition: the case of Honduras Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 GAVI Support for Honduras Content Honduras EPI Situation 2011-2016 Vaccination
How does Gavi make vaccine investment decisions?
How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)
2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
How to present the European Vaccine Action Plan (EVAP)
How to present the European Vaccine Action Plan 2015-2020 () HOW TO USE THIS DOCUMENT By adopting the European Vaccine Action Plan 2015-2020 () in September 2014, all Member States of the WHO European
C o n t e n t s. > Immunizations 4. > Diphtheria 6. > Pertussis 7. > Tetanus 8. > Polio 9. > Measles 10. > Tuberculosis 11.
C o n t e n t s > Immunizations 4 > Diphtheria 6 > Pertussis 7 > Tetanus 8 > Polio 9 > Measles 1 > Tuberculosis 11 > Hepatitis B 12 > Rubella and CRS 13 > Haemophius Influenza B 14 I m m u n i z a t i
Polio and routine immunisation Alan Brooks
Polio and routine immunisation Alan Brooks Geneva, Switzerland, Background 1 History of polio eradication World Health Assembly Resolution 400 Previous eradication targets Polio cases (thousands) 300 200